In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of adults with schizophrenia. In an earlier post, we reviewed evidence that this ...

An association between oral microbiota and cognitive performance in schizophrenia has been reported by researchers at Science Tokyo. By analyzing saliva samples and cognitive test scores from patients ...

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably higher likelihood of developing non-amnestic mild cognitive impairment.

A new study reveals that COVID-19 patients suffer from significant, long-term cognitive deficits even a year after hospitalization, with brain injury markers and reduced brain volume suggesting immune ...

Cognitive rehabilitation is an umbrella term for a group of targeted exercises and activities that aim to improve or stabilize cognitive impairments as well as any changes in a person’s everyday ...

The effects of sustained drug abuse can manifest in many ways. Loss of memory and reduced cognitive functions are some of the effects that can persist for years. Scientists have now identified a ...

ADHD is a common neurodevelopmental disorder marked by symptoms of inattention, impulsivity, and hyperactivity. While it is often diagnosed in childhood, many people continue to experience symptoms ...